A detailed history of Boothbay Fund Management, LLC transactions in Vericel Corp stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 5,969 shares of VCEL stock, worth $352,827. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,969
Holding current value
$352,827
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$42.25 - $53.56 $252,190 - $319,699
5,969 New
5,969 $252,000
Q2 2022

Aug 15, 2022

BUY
$22.88 - $39.45 $223,789 - $385,860
9,781 New
9,781 $246,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.79B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.